Spots Global Cancer Trial Database for afp464 + faslodex
Every month we try and update this database with for afp464 + faslodex cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study of AFP464 +/- Faslodex in ER + Breast Cancer | NCT01233947 | Breast Neoplasm | AFP464 AFP464 + Faslod... | 18 Years - | Tigris Pharmaceuticals |